A new treatment for Lyme disease?
Medical News Today - 10/20/2021
“Nobody really cared about that compound ever since because it’s very weak against regular bacteria,” says Prof. Kim Lewis, of Northeastern University College of Science, Boston, MA, and co-lead author of the present study. “What we discovered is that, yeah, it is very weak against regular pathogens, but exceptionally potent against spirochetes.”